Share on StockTwits

Stryker (NYSE:SYK) Director Ronda E. Stryker unloaded 14,000 shares of the company’s stock on the open market in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $81.46, for a total transaction of $1,140,440.00. Following the transaction, the director now directly owns 174,605 shares in the company, valued at approximately $14,223,323. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Shares of Stryker (NYSE:SYK) traded up 0.81% on Tuesday, hitting $81.98. 931,831 shares of the company’s stock traded hands. Stryker has a 52 week low of $66.44 and a 52 week high of $86.93. The stock’s 50-day moving average is $81.81 and its 200-day moving average is $81.3. The company has a market cap of $31.036 billion and a P/E ratio of 45.43.

Stryker (NYSE:SYK) last released its earnings data on Thursday, July 17th. The company reported $1.08 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $1.08. The company had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the prior year, the company posted $1.00 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. On average, analysts predict that Stryker will post $4.77 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a dividend yield of 1.49%. The ex-dividend date is Friday, September 26th.

A number of research firms have recently commented on SYK. Analysts at Needham & Company LLC upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Tuesday, August 12th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Stryker in a research note on Monday, July 21st. They now have a $86.00 price target on the stock. Finally, analysts at Citigroup Inc. reiterated a “neutral” rating on shares of Stryker in a research note on Monday, July 21st. They now have a $90.00 price target on the stock, up previously from $85.00. Eight research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $86.18.

Stryker Corporation (NYSE:SYK) is a medical technology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.